Search details
1.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38682738
2.
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
J Oncol Pharm Pract
; 29(7): 1748-1753, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37282554
3.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Article
in English
| MEDLINE | ID: mdl-35920559
4.
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).
Eur J Nucl Med Mol Imaging
; 49(3): 1063-1074, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34486070
5.
Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient.
Anticancer Drugs
; 33(1): e724-e729, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34261919
6.
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(5)2021 Mar 05.
Article
in English
| MEDLINE | ID: mdl-33807876
7.
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
Clin Genitourin Cancer
; 22(2): 126-133.e2, 2024 04.
Article
in English
| MEDLINE | ID: mdl-37932204
8.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Article
in English
| MEDLINE | ID: mdl-38410103
9.
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Minerva Urol Nephrol
; 75(3): 308-318, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36511379
10.
Reliability of patient-reported toxicities during adjuvant chemotherapy.
Eur J Cancer
; 182: 115-121, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36758476
11.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Cancers (Basel)
; 15(8)2023 Apr 21.
Article
in English
| MEDLINE | ID: mdl-37190322
12.
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report.
Immunotherapy
; 14(18): 1419-1427, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36597723
13.
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
Ther Adv Med Oncol
; 14: 17588359221079580, 2022.
Article
in English
| MEDLINE | ID: mdl-35237353
14.
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
Curr Oncol
; 29(10): 7745-7753, 2022 10 14.
Article
in English
| MEDLINE | ID: mdl-36290889
15.
Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenarios.
Immunotherapy
; 13(8): 645-652, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33823647
16.
Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: a case report.
Immunotherapy
; 13(17): 1379-1386, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34743545
17.
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence.
Cancers (Basel)
; 13(21)2021 Nov 03.
Article
in English
| MEDLINE | ID: mdl-34771680
18.
The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study.
Cancers (Basel)
; 12(11)2020 Oct 31.
Article
in English
| MEDLINE | ID: mdl-33142739
Results
1 -
18
de 18
1
Next >
>>